Drugs / BI 764122
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03794323 | Jan → Aug 2019 | — | Boehringer Ingelheim | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BI 764122 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03794323 ↗ |
| Route | Oral | “administered as single oral dose” NCT03794323 ↗ |